ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
비강 코르티코스테로이드 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 8.1%로 91억 4,000만 달러로 성장합니다. 예측 기간 중 비침습적 약물전달 방식에 대한 관심 증가, 비강내 약물 개발에 대한 투자 증가, 개발도상국의 의료 접근성 개선, 비강내 약물 병용 치료에 대한 수요 증가, 비강내 약물에 대한 E-Commerce 채널 확대 등이 성장 전망의 배경이 되고 있습니다. 이 기간 중 예상되는 주요 동향으로는 비강 투여 기술의 발전, 병용요법의 제형 강화, 일반의약품의 도입, 소아 친화적 비강 분무제의 혁신, 방부제 없는 비강 분무제의 선택권 창출 등이 있습니다.
호흡기 질환의 유병률 증가는 비강용 코르티코스테로이드 시장의 향후 성장을 가속할 것으로 예측됩니다. 호흡기 질환은 호흡을 어렵게 하는 폐에 영향을 미치는 건강 상태를 포함하며, 종종 기침, 호흡곤란 등의 증상을 유발합니다. 이러한 증가는 대기오염의 악화, 유해한 오염물질에 대한 노출, 흡연, 신체활동의 제한을 특징으로 하는 현대인의 좌식 생활습관이 주요 원인이며, 이 모든 것이 폐 건강에 악영향을 미치고 호흡기 질환의 위험을 증가시킵니다. 비강용 코르티코스테로이드는 비강내 염증을 억제하고, 호흡을 편안하게 하며, 코막힘, 재채기 등의 증상을 완화하고, 공기 흐름을 원활하게 하여 호흡을 편안하게 함으로써 호흡기 질환 관리에 도움을 줍니다. 예를 들어 2025년 6월 영국 정부 부처인 Office for Health Improvement and Disparities는 2023-2024 회계연도 동안 영국에서 호흡기 질환으로 인한 응급 입원이 7% 증가했으며, 특히 COPD는 9%, 성인 천식은 17%, 폐렴은 16% 증가했다고 보고했습니다. 17%, 폐렴은 16% 증가했다고 보고했습니다. 그 결과, 호흡기 질환 발생률 증가는 비강용 코르티코스테로이드 시장의 성장을 가속하고 있습니다.
비강용 코르티코스테로이드 시장의 주요 기업은 약물전달 효율, 치료 결과, 환자 순응도를 개선하기 위해 호흡 전달 시스템(EDS)을 이용한 비강 스프레이와 같은 혁신적인 치료법에 대한 규제 당국의 승인을 획득하는 데 주력하고 있습니다. EDS 기반 비강 점안제는 환자의 호흡을 이용하여 연약한 입천장을 닫고 약물을 비강 깊숙이 주입하여 염증 부위에 약물이 침착되도록 촉진합니다. 예를 들어 2024년 5월 미국 제약회사 옵티노스(Optinose, Inc.)는 비용종이 없는 만성 비부비동염(CRSsNP) 성인에게 적응증이 있는 최초이자 유일한 약물인 XHANCE(플루티카손 프로피오네이트) 비강 분무제의 FDA 승인을 받았습니다. XHANCE는 독자적인 EDS 기술을 채택하여 부드러운 호흡을 통해 코르티코스테로이드를 비강 깊숙이 전달하여 만성 비부비동염에 특화된 항염증 효과를 가져옵니다. 이 접근법은 약물이 잘 전달되지 않는 기존의 비강 점안제를 대체할 수 있습니다. XHANCE는 비용종이 없는 만성 비부비동염과 관련된 코막힘과 안면 압박을 완화하고, 침습적 시술이나 경구용 코르티코스테로이드에서 흔히 나타나는 전신 부작용을 피하면서 증상을 장기적으로 관리할 수 있도록 돕습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 비강 코르티코스테로이드 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 비강 코르티코스테로이드 시장 : 성장률 분석
세계의 비강 코르티코스테로이드 시장 실적 : 규모와 성장, 2019-2024
세계의 비강 코르티코스테로이드 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 비강 코르티코스테로이드 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 비강 코르티코스테로이드 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
수성 비강 스프레이
비수성 비강 스프레이
세계의 비강 코르티코스테로이드 시장 : 약제 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
Fluticasone Propionate
Budesonide
Beclomethasone Dipropionate
Mometasone Furoate
Triamcinolone Acetonide
Ciclesonide
기타 약제 유형
세계의 비강 코르티코스테로이드 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
기타 유통 채널
세계의 비강 코르티코스테로이드 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
알레르기성 비염
코폴립
부비강염
기타 용도
세계의 비강 코르티코스테로이드 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
클리닉
홈케어 설정
기타 최종사용자
세계의 비강 코르티코스테로이드 시장 : 서브 세분화, 수성 비강 스프레이(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
정량 분무식 수성 비강 스프레이
펌프 액션 수성 비강 스프레이
세계의 비강 코르티코스테로이드 시장 : 서브 세분화, 비수성 비강 스프레이(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
수성 알코올 비강 스프레이
오일 베이스 비강 스프레이
제7장 지역별·국가별 분석
세계의 비강 코르티코스테로이드 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 비강 코르티코스테로이드 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
비강 코르티코스테로이드 시장 : 경쟁 구도
비강 코르티코스테로이드 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
Bayer AG Overview, Products and Services, Strategy and Financial Analysis
Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
GSK plc Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Amgen Inc.
Viatris Inc.
Teva Pharmaceutical Industries Ltd.
Sandoz International GmbH
Sun Pharmaceutical Industries Ltd.
Apotex Inc.
Perrigo Company plc
Aurobindo Pharma Limited
Cipla Limited
Glenmark Pharmaceuticals Ltd
Alkem Laboratories Ltd
Pharmascience Inc.
Mylan N.V
Aspire Pharma(UK)
AdvaCare Pharma
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
비강 코르티코스테로이드 시장 2029 : 새로운 기회를 제공하는 국가
비강 코르티코스테로이드 시장 2029 : 새로운 기회를 제공하는 부문
비강 코르티코스테로이드 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Nasal corticosteroids are corticosteroid drugs administered through the nose, usually as nasal sprays, to decrease inflammation within the nasal passages. They are frequently prescribed for conditions like allergic rhinitis, nasal polyps, and chronic sinusitis, helping to alleviate symptoms such as nasal congestion, sneezing, and a runny nose by reducing swelling and irritation of the nasal lining.
The primary types of nasal corticosteroid products include aqueous nasal sprays and non-aqueous nasal sprays. Aqueous nasal sprays are water-based formulations designed to deliver medication directly into the nasal cavities. These products contain various active ingredients such as fluticasone propionate, budesonide, beclomethasone dipropionate, mometasone furoate, triamcinolone acetonide, ciclesonide, among others. They are distributed through multiple channels including hospital pharmacies, retail pharmacies, and online pharmacies, serving applications like allergic rhinitis, nasal polyps, and sinusitis. The end users range from hospitals and clinics to homecare settings.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The nasal corticosteroids market research report is one of a series of new reports from The Business Research Company that provides nasal corticosteroids market statistics, including nasal corticosteroids industry global market size, regional shares, competitors with a nasal corticosteroids market share, nasal corticosteroids market segments, market trends and opportunities, and any further data you may need to thrive in the nasal corticosteroids industry. This nasal corticosteroids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The nasal corticosteroids market size has grown strongly in recent years. It will grow from $6.19 billion in 2024 to $6.70 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The expansion during the historical period is driven by greater awareness of nasal corticosteroid therapies, a rising number of chronic sinusitis cases, increased use of over-the-counter nasal sprays, heightened emphasis on outpatient care, and wider availability of generic products.
The nasal corticosteroids market size is expected to see strong growth in the next few years. It will grow to $9.14 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The projected growth during the forecast period is fueled by an increasing emphasis on non-invasive drug delivery methods, rising investments in intranasal drug development, improved healthcare access in developing regions, growing demand for combination nasal treatments, and expanding e-commerce channels for nasal medications. Key trends expected in this period include advancements in intranasal delivery technologies, enhanced formulations of combination therapies, the introduction of over-the-counter nasal corticosteroids, innovations in pediatric-friendly nasal sprays, and the creation of preservative-free nasal spray options.
The rising prevalence of respiratory diseases is expected to drive the growth of the nasal corticosteroids market in the future. Respiratory diseases involve health conditions affecting the lungs that make breathing difficult, often causing symptoms like coughing or shortness of breath. This increase is largely attributed to worsening air pollution and modern sedentary lifestyles characterized by exposure to harmful pollutants, smoking, and limited physical activity, all of which negatively affect lung health and raise the risk of respiratory issues. Nasal corticosteroids aid in managing respiratory diseases by reducing inflammation in the nasal passages, easing breathing, relieving symptoms such as congestion and sneezing, and improving airflow for greater respiratory comfort. For example, in June 2025, the Office for Health Improvement and Disparities, a UK government department, reported that between the financial years ending 2023 and 2024, emergency admissions for respiratory diseases in England increased by 7%, with specific rises of 9% for COPD, 17% for adult asthma, and 16% for pneumonia. Consequently, the increasing incidence of respiratory diseases is fueling the nasal corticosteroids market growth.
Key companies in the nasal corticosteroids market are focusing on obtaining regulatory approvals for innovative treatments, such as nasal sprays using exhalation delivery systems (EDS), to improve drug delivery efficiency, treatment outcomes, and patient adherence. EDS-based nasal sprays use the patient's exhaled breath to close the soft palate and deliver medication deep into the nasal passages, enhancing drug deposition in inflamed areas. For instance, in May 2024, Optinose, Inc., a US-based pharmaceutical company, received FDA approval for XHANCE (fluticasone propionate) nasal spray, the first and only medication indicated for adults with chronic rhinosinusitis without nasal polyps (CRSsNP). XHANCE employs a unique EDS technology that delivers corticosteroids deeply into the nasal passages through gentle exhalation, providing targeted anti-inflammatory effects for chronic rhinosinusitis. This approach offers an alternative to conventional nasal sprays, which often have limited reach, by ensuring medication reaches hard-to-access inflamed sites. XHANCE helps alleviate nasal congestion and facial pressure related to chronic rhinosinusitis without nasal polyps and supports long-term management of the condition while avoiding invasive procedures and systemic side effects commonly seen with oral corticosteroids.
In March 2025, Paratek Pharmaceuticals Inc., a US-based biopharmaceutical company, acquired Optinose Inc. for an undisclosed amount. Through this acquisition, Paratek Pharmaceuticals intends to enhance its position in the respiratory and ear, nose, and throat (ENT) therapeutics market and broaden its portfolio with innovative nasal drug delivery products such as Optinose's XHANCE. Optinose Inc. is a US-based pharmaceutical company specializing in nasal corticosteroids.
Major players in the nasal corticosteroids market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., GSK plc, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Apotex Inc., Perrigo Company plc, Aurobindo Pharma Limited, Cipla Limited, Glenmark Pharmaceuticals Ltd, Alkem Laboratories Ltd, Pharmascience Inc., Mylan N.V., Aspire Pharma (UK), and AdvaCare Pharma.
North America was the largest region in the nasal corticosteroids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nasal corticosteroids report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the nasal corticosteroids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The nasal corticosteroids market includes sales of sprays, inhalers, drops, gels, and ointments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Nasal Corticosteroids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on nasal corticosteroids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for nasal corticosteroids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nasal corticosteroids market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
2) By Drug Type: Fluticasone Propionate; Budesonide; Beclomethasone Dipropionate; Mometasone Furoate; Triamcinolone Acetonide; Ciclesonide; Other Drug Types
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
4) By Application: Allergic Rhinitis; Nasal Polyps; Sinusitis; Other Applications
5) By End-User: Hospitals; Clinics; Homecare Settings; Other End-Users
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Nasal Corticosteroids Market Characteristics
3. Nasal Corticosteroids Market Trends And Strategies
4. Nasal Corticosteroids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Nasal Corticosteroids Growth Analysis And Strategic Analysis Framework
5.1. Global Nasal Corticosteroids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Nasal Corticosteroids Market Growth Rate Analysis
5.4. Global Nasal Corticosteroids Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Nasal Corticosteroids Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Nasal Corticosteroids Total Addressable Market (TAM)
6. Nasal Corticosteroids Market Segmentation
6.1. Global Nasal Corticosteroids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Aqueous Nasal Sprays
Non-Aqueous Nasal Sprays
6.2. Global Nasal Corticosteroids Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fluticasone Propionate
Budesonide
Beclomethasone Dipropionate
Mometasone Furoate
Triamcinolone Acetonide
Ciclesonide
Other Drug Types
6.3. Global Nasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
6.4. Global Nasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Allergic Rhinitis
Nasal Polyps
Sinusitis
Other Applications
6.5. Global Nasal Corticosteroids Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Homecare Settings
Other End-Users
6.6. Global Nasal Corticosteroids Market, Sub-Segmentation Of Aqueous Nasal Sprays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Metered-Dose Aqueous Nasal Sprays
Pump-Action Aqueous Nasal Sprays
6.7. Global Nasal Corticosteroids Market, Sub-Segmentation Of Non-Aqueous Nasal Sprays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hydroalcoholic Nasal Sprays
Oil-Based Nasal Sprays
7. Nasal Corticosteroids Market Regional And Country Analysis
7.1. Global Nasal Corticosteroids Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Nasal Corticosteroids Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Nasal Corticosteroids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Nasal Corticosteroids Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Nasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Nasal Corticosteroids Market
9.1. China Nasal Corticosteroids Market Overview
9.2. China Nasal Corticosteroids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Nasal Corticosteroids Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Nasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Nasal Corticosteroids Market
10.1. India Nasal Corticosteroids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Nasal Corticosteroids Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Nasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Nasal Corticosteroids Market
11.1. Japan Nasal Corticosteroids Market Overview
11.2. Japan Nasal Corticosteroids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Nasal Corticosteroids Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Nasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Nasal Corticosteroids Market
12.1. Australia Nasal Corticosteroids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Nasal Corticosteroids Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Nasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Nasal Corticosteroids Market
13.1. Indonesia Nasal Corticosteroids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Nasal Corticosteroids Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Nasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Nasal Corticosteroids Market
14.1. South Korea Nasal Corticosteroids Market Overview
14.2. South Korea Nasal Corticosteroids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Nasal Corticosteroids Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Nasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Nasal Corticosteroids Market
15.1. Western Europe Nasal Corticosteroids Market Overview
15.2. Western Europe Nasal Corticosteroids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Nasal Corticosteroids Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Nasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Nasal Corticosteroids Market
16.1. UK Nasal Corticosteroids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Nasal Corticosteroids Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Nasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Nasal Corticosteroids Market
17.1. Germany Nasal Corticosteroids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Nasal Corticosteroids Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Nasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Nasal Corticosteroids Market
18.1. France Nasal Corticosteroids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Nasal Corticosteroids Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Nasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Nasal Corticosteroids Market
19.1. Italy Nasal Corticosteroids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Nasal Corticosteroids Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Nasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Nasal Corticosteroids Market
20.1. Spain Nasal Corticosteroids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Nasal Corticosteroids Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Nasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Nasal Corticosteroids Market
21.1. Eastern Europe Nasal Corticosteroids Market Overview
21.2. Eastern Europe Nasal Corticosteroids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Nasal Corticosteroids Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Nasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Nasal Corticosteroids Market
22.1. Russia Nasal Corticosteroids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Nasal Corticosteroids Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Nasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Nasal Corticosteroids Market
23.1. North America Nasal Corticosteroids Market Overview
23.2. North America Nasal Corticosteroids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Nasal Corticosteroids Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Nasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Nasal Corticosteroids Market
24.1. USA Nasal Corticosteroids Market Overview
24.2. USA Nasal Corticosteroids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Nasal Corticosteroids Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Nasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
